Poland· PL-100134915
Relestat
A epinastine product containing epinastini hydrochloridum, registered in Poland by AbbVie Sp. z o.o.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Epinastine is registered in 8 of 19 countries.
Countries holding a registration under ATC S01GX10 (epinastine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Epinastine · ATC S01GX10
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Epinastini hydrochloridum
- Manufacturer
- AbbVie Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01GX10
- ATC class
- Epinastine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990215591
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epinastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRelestat 0.5 mg/mlAbbvie
- CzechiaPURIVISTAbbVie s.r.o., Praha
- FinlandRelestatAllergan Pharmaceuticals Ireland
- FrancePURIVIST 0,5 mg/ml, collyre en solutionABBVIE
- IrelandRelestat, 0.5 mg/ml, eye drops, solutionAbbVie Limited
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- SwedenRelestat 0,5 mg/ml Ögondroppar, lösningAbbVie AB
- United StatesEPINASTINE HYDROCHLORIDESomerset Therapeutics, LLC
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Relestat
- Czechia · Purivist
- France · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Ireland · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Sweden · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d22f42c-fe5c-4454-8293-a30624cc99bd GET /v1/drugs/4d22f42c-fe5c-4454-8293-a30624cc99bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "0,5 mg/ml",
"packaging": "05909990215591 ¦ Rp ¦ 26527\n1 butelka 5 ml",
"substance": "Epinastyny chlorowodorek 0.5 mg/ml",
"common_name": "Epinastini hydrochloridum",
"pl_product_id": "100134915",
"pozwolenie_nr": "11386",
"auth_procedure": "MRP",
"authorisation_validity": "2024-08-08"
}See everything about epinastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.